Ledger.Open graph →
SEC Form D · filed January 9, 2014

NeuroGenetic Pharmaceuticals, Inc

Offering
$110K
Sold
$100K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
DEL MAR, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Barry T. Quart · Del Mar, CADirectorTom T. Reed · Del Mar, CADirectorWilliam T. Comer · Del Mar, CAExec · DirectorMichael P. Knapp · NEW YORK, NYDirectorRichard A. Baker · NEW YORK, NYDirectorMichael J. Fox · NEW YORK, NYExec · DirectorVikram Deswal · Boston, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗